Effect of P2Y12 Inhibitor Monotherapy vs Dual Antiplatelet Therapy on Cardiovascular Events in Patients Undergoing Percutaneous Coronary Intervention

Hahn, Joo‐Yong; Bin Song, Young; Hyeon Oh, Ju; Jung Chun, Woo; Hwan Park, Yong; Jin Jang, Woo; Im, Eul‐Soon; Jeong, Jin‐Ok; Ryul Cho, Byung; Kyu Oh, Seok; Ho Yun, Kyeong; Cho, Deok‐Kyu; Lee, Jong‐Young; Youp Koh, Young; Bae, Jang‐Whan; Woong Choi, Jae; Soo Lee, Wang; Yoon, Hyuck‐Jun; Uk Lee, Seung; Hyun Cho, Jang; Choi, Woong; Rha, Seung‐Woon; Myung Lee, Joo; Kyu Park, Taek; Hoon Yang, Jeong; Choi, Jin‐Ho; Choi, Seung‐Hyuck; Hoon Lee, Sang; Gwon, Hyeon‐Cheol; the SMART-CHOICE Investigators, for

doi:10.1001/jama.2019.8146

Public

Effect of P2Y12 Inhibitor Monotherapy vs Dual Antiplatelet Therapy on Cardiovascular Events in Patients Undergoing Percutaneous Coronary Intervention

Published in JAMA • Jun 25, 2019

Authors:

Joo‐Yong Hahn

Young Bin Song

Ju Hyeon Oh

Abstract

Importance: Data on P2Y12 inhibitor monotherapy after short-duration dual antiplatelet therapy (DAPT) in patients undergoing percutaneous coronary intervention are limited. Objective: To determine whether P2Y12 inhibitor monotherapy after 3 months of DAPT is noninferior to 12 months of DAPT in patie...

Subject

Medicine

Percutaneous coronary intervention

Conventional PCI

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!